Systemic reactions to inhalant immunotherapy using 1:1 target dosing

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 5, 2014, Pages 453-458

  Holland, Christine L ^a   Samuels, Kiela M ^a,b   Baldwin, James L ^a   Greenhawt, Matthew J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT;

ABDOMINAL CRAMP; ABNORMAL SENSATION; ADULT; AGED; ALLERGIC REACTION; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; COHORT ANALYSIS; CONJUNCTIVA DISEASE; CONJUNCTIVAL ERYTHEMA; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPNEA; EPIPHORA; ERYTHEMA; FEMALE; HEADACHE; HOT FLUSH; HUMAN; HYPOTENSION; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; NASAL PRURITUS; NAUSEA; NOSE OBSTRUCTION; PRIORITY JOURNAL; PRURITUS; REACTION TIME; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RHINITIS; RHINORRHEA; SEX DIFFERENCE; SUBCUTANEOUS IMMUNOTHERAPY; SYSTEMIC ANAPHYLAXIS; THROAT IRRITATION; TIME TO TREATMENT; TONGUE EDEMA; UNCONSCIOUSNESS; URTICARIA; UTERINE CRAMP; UTERUS DISEASE; VOMITING; WHEEZING;

ADOLESCENT; ADULT; AGED; ALLERGENS; ASTHMA; COHORT STUDIES; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INHALATION; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84899574932     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.02.008     Document Type: Article

References (36)

1. F.C. Lowell, and W. Franklin A double-blind study of the effectiveness and specificity of injecton therapy in ragweed hay fever N Engl J Med 273 1965 675 679
2. J. Bousquet, R. Lockey, and H.J. Malling et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases Ann Allergy Asthma Immunol 81 1998 401 405
3. R.N. Ross, H.S. Nelson, and I. Finegold Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies Clin Ther 22 2000 342 350
4. R.F. Lockey "ARIA": global guidelines and new forms of allergen immunotherapy J Allergy Clin Immunol 108 2001 497 499
5. American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology. Allergen immunotherapy: a practice parameter Ann Allergy Asthma Immunol 90 2003 1 40
6. A.J. Frew, R.J. Powell, C.J. Corrigan, and S.R. Durham Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis J Allergy Clin Immunol 117 2006 319 325
7. Allergen immunotherapy a practice parameter second update J Allergy Clin Immunol 120 2007 S25 S85
8. M.J. Abramson, R.M. Puy, and J.M. Weiner Injection allergen immunotherapy for asthma Cochrane Database Syst Rev 2010 CD001186
9. L. Cox, H. Nelson, and R. Lockey et al. Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 2011 S1 S55
10. E. Alvarez-Cuesta, J. Cuesta-Herranz, J. Puyana-Ruiz, C. Cuesta-Herranz, and A. Blanco-Quiros Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study J Allergy Clin Immunol 93 1994 556 566
11. A. Des Roches, L. Paradis, and J. Knani et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract, V: duration of the efficacy of immunotherapy after its cessation Allergy 51 1996 430 433
12. P.A. Ewbank, J. Murray, K. Sanders, D. Curran-Everett, S. Dreskin, and H.S. Nelson A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract J Allergy Clin Immunol 111 2003 155 161
13. A. Nanda, M. O'Connor, and M. Anand et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract J Allergy Clin Immunol 114 2004 1339 1344
14. L. Cox Standardized allergen extracts: past, present and future Expert Rev Clin Immunol 1 2005 579 588
15. A.M. Lent, R. Harbeck, and M. Strand et al. Immunologic response to administration of standardized dog allergen extract at differing doses J Allergy Clin Immunol 118 2006 1249 1256
16. C.K. Niu, W.Y. Chen, J.L. Huang, K.H. Lue, and J.Y. Wang Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan Respir Med 100 2006 1374 1383
17. F.V. Ragusa, G. Passalacqua, and R. Gambardella et al. Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience J Investig Allergol Clin Immunol 7 1997 151 154
18. R.F. Lockey, G.L. Nicoara-Kasti, D.S. Theodoropoulos, and S.C. Bukantz Systemic reactions and fatalities associated with allergen immunotherapy Ann Allergy Asthma Immunol 87 2001 47 55
19. G. Gastaminza, J. Algorta, M. Audicana, M. Etxenagusia, E. Fernandez, and D. Munoz Systemic reactions to immunotherapy: influence of composition and manufacturer Clin Exp Allergy 33 2003 470 474
20. J.M. Kelso The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction Ann Allergy Asthma Immunol 92 2004 225 227
21. C. Moreno, J. Cuesta-Herranz, L. Fernandez-Tavora, and E. Alvarez-Cuesta Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases Clin Exp Allergy 34 2004 527 531
22. V.F. Ragusa, and A. Massolo Non-fatal systemic reactions to subcutaneous immunotherapy: a 20-year experience comparison of two 10-year periods Eur Ann Allergy Clin Immunol 36 2004 52 55
23. S.R. Roy, J.R. Sigmon, J. Olivier, J.E. Moffitt, D.A. Brown, and G.D. Marshall Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy Ann Allergy Asthma Immunol 99 2007 82 86
24. J.R. Montgomery The need for standardizing the aeroallergen immunotherapy missed-dose adjustment protocol Allergy Asthma Proc 29 2008 425 426
25. M.A. Rank, C.L. Oslie, J.L. Krogman, M.A. Park, and J.T. Li Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors Allergy Asthma Proc 29 2008 400 405
26. C.W. Calabria, C.A. Coop, and M.S. Tankersley The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy J Allergy Clin Immunol 124 2009 739 744
27. O. Pfaar, C. Anders, and L. Klimek Clinical outcome measures of specific immunotherapy Curr Opin Allergy Clin Immunol 9 2009 208 213
28. S.E. Scranton, E.G. Gonzalez, and K.H. Waibel Incidence and characteristics of biphasic reactions after allergen immunotherapy J Allergy Clin Immunol 123 2009 493 498
29. D.I. Bernstein, T. Epstein, K. Murphy-Berendts, and G.M. Liss Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study Ann Allergy Asthma Immunol 104 2010 530 535
30. R. Confino-Cohen, and A. Goldberg Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study Ann Allergy Asthma Immunol 104 2010 73 78
31. L. Cox, D. Larenas-Linnemann, R.F. Lockey, and G. Passalacqua Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System J Allergy Clin Immunol 125 2010 569 574
32. S.F. Kemp, R.F. Lockey, and F.E. Simons Epinephrine: the drug of choice for anaphylaxis: a statement of the World Allergy Organization Allergy 63 2008 1061 1070
33. L. Nielsen, C.R. Johnsen, H. Mosbech, L.K. Poulsen, and H.J. Malling Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study J Allergy Clin Immunol 97 1996 1207 1213
34. K. Brockow, M. Kiehn, C. Riethmuller, D. Vieluf, J. Berger, and J. Ring Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial J Allergy Clin Immunol 100 1997 458 463
35. U. Muller, Y. Hari, and E. Berchtold Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy J Allergy Clin Immunol 107 2001 81 86
36. Y. Ohashi, Y. Nakai, and K. Murata Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis Ann Allergy Asthma Immunol 96 2006 600 605